1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. MULTIPLEX ASSAY MARKET BY TYPE
5.1. Introduction
5.2. Protein Multiplex Assays
5.3. Nucleic Acid Multiplex Assays
5.4. Cell-based Multiples Assays
6. MULTIPLEX ASSAY MARKET BY PRODUCT
6.1. Introduction
6.2. Consumables
6.3. Instruments
6.4. Software
7. MULTIPLEX ASSAY MARKET BY TECHNOLOGY
7.1. Introduction
7.2. Flow Cytometry
7.3. Fluorescence Detection
7.4. Luminescence
7.5. Multiplex Real-time PCR
7.6. Other Technologies
8. MULTIPLEX ASSAY MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Luminex
10.2. Promega
10.3. Rndsystems (Biotechne Corporation)
10.4. Eve Technologies
10.5. Sigma-Aldrich
10.6. Bio-Techne
10.7. Merck Millipore
10.8. Biocompare
10.9. Flagship Biosciences
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES